Ezallor Sprinkle (Rosuvastatin Calcium) Patent Expiration, LOE Window & CMS Spending

Ezallor Sprinkle (Rosuvastatin Calcium) by Sun Pharmaceutical: FDA Orange Book LOE 2036-02-12, 19 AB generics, $8K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorSun Pharmaceutical
FDA Application & PathwayN208647 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2036-02-12
Orange Book Patents (*PED Extensions)1 patents (0 *PED)
Active AB-Rated Generic Competitors19
2024 CMS Total Public Spend$8K
2024 Medicare Part D Spend$6K
2024 Medicaid Spend$2K
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel